Clinical Trial Update: Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating the safety and preliminary efficacy of venetoclax combined with Vyxeos (CPX-351) in patients with relapsed or refrac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Venclexta (venetoclax)
• Vyxeos (CPX-351)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Leukemia | Phase 1 | Status: RECRUITING